Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR441566 plus methotrexate in adults with moderate-to-severe rheumatoid arthritis
jRCT2041230128Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2024
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of balinatunfib in rheumatoid arthritis (RA) (5 arms), sponsored by Sanofi. Primary endpoint: ACR20 response at week 12. Started Feb 2024; status: completed.
02
Drugs
balinatunfib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT2041230128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2041230128.